← All trials
NCT04654182
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2020
- Primary completion
- Dec 24, 2020
- Completion date
- Dec 24, 2020
- First posted
- Dec 4, 2020
- Last posted
- Dec 4, 2020
- Enrollment
- 32
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Molnlycke Health Care ABLead sponsor
- Bio-Science LaboratoriesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.